Critical role of neutralizing antibody for SARS-CoV-2 reinfection and transmission

References

• Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–733.
   PubMed Web of Science ®Google Scholar
• CSG of the International. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbio. 2020;5(4):536.
   Web of Science ®Google Scholar
• Organization WH. WHO director-general’s opening remarks at the media briefing on COVID-19-11 March 2020. 2020.
   Google Scholar
• WHO. Coronavirus disease (COVID-19) weekly epidemiological update and weekly operational update 2020 [cited 2020 Sept 17]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports.
   Google Scholar
• Randolph HE, Barreiro LB. Herd immunity: understanding COVID-19. Immunity. 2020;52(5):737–741.
   PubMed Web of Science ®Google Scholar
• WHO. “Immunity passports” in the context of COVID-19 2020 [cited 2020 April 24]. Available from: https://www.who.int/news-room/commentaries/detail/immunity-passports-in-the-context-of-covid-19.
   Google Scholar
• Kumar S, Nyodu R, Maurya VK, et al. Host immune response and immunobiology of human SARS-CoV-2 infection. Coronavirus disease 2019 (COVID-19). Singapore: Springer; 2020. p. 43–53.
   Google Scholar
• Wu F, Wang A, Liu M, et al. Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications; 2020.
   Google Scholar
• Choe PG, Perera R, Park WB, et al. MERS-CoV antibody responses 1 year after symptom onset, South Korea, 2015. Emerging Infect Dis. 2017;23(7):1079.
   PubMed Web of Science ®Google Scholar
• Wu L-P, Wang N-C, Chang Y-H, et al. Duration of antibody responses after severe acute respiratory syndrome. Emerging Infect Dis. 2007;13(10):1562.
   PubMed Web of Science ®Google Scholar
• Cao W-C, Liu W, Zhang P-H, et al. Disappearance of antibodies to SARS-associated coronavirus after recovery. N Engl J Med. 2007;357(11):1162–1163.
   PubMed Web of Science ®Google Scholar
• Bao L, Deng W, Gao H, et al. Reinfection could not occur in SARS-CoV-2 infected rhesus macaques. bioRxiv. 2020.
   Google Scholar
• Kiyuka PK, Agoti CN, Munywoki PK, et al. Human coronavirus NL63 molecular epidemiology and evolutionary patterns in rural coastal Kenya. J Infect Dis. 2018;217(11):1728–1739.
   PubMed Web of Science ®Google Scholar
• Houser KV, Broadbent AJ, Gretebeck L, et al. Enhanced inflammation in New Zealand white rabbits when MERS-CoV reinfection occurs in the absence of neutralizing antibody. PLoS Pathog. 2017;13(8):e1006565.
   PubMed Web of Science ®Google Scholar
• Kliks SC, Nisalak A, Brandt WE, et al. Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am J Trop Med Hyg. 1989;40(4):444–451.
   Web of Science ®Google Scholar
• Olsen CW, Corapi W, Ngichabe C, et al. Monoclonal antibodies to the spike protein of feline infectious peritonitis virus mediate antibody-dependent enhancement of infection of feline macrophages. J Virol. 1992;66(2):956–965.
   Web of Science ®Google Scholar
• An J, Liao X, Xiao T, et al. Clinical characteristics of the recovered COVID-19 patients with re-detectable positive RNA test. MedRxiv. 2020.
   Google Scholar
• Gong SE. In South Korea, A Growing Number Of COVID-19 Patients Test Positive After Recovery npr2020 [cited 220 April 17]. Available from: https://www.npr.org/sections/coronavirus-live-updates/2020/04/17/836747242/in-south-korea-a-growing-number-of-covid-19-patients-test-positive-after-recover.
   Google Scholar
• Kim Y-I, Kim S-G, Kim S-M, et al. Infection and rapid transmission of SARS-CoV-2 in ferrets. Cell Host Microbe. 2020;27(5):704–709.
   PubMed Web of Science ®Google Scholar
• Shi J, Wen Z, Zhong G, et al. Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS–coronavirus 2. Science. 2020;368(6494):1016–1020.
   PubMed Web of Science ®Google Scholar
• Klasse P. Neutralization of virus infectivity by antibodies: old problems in new perspectives. Adv Biol. 2014;2014:157895.
   Google Scholar
• Okba NM, Müller MA, Li W, et al. Severe acute respiratory syndrome coronavirus 2-specific antibody responses in coronavirus disease patients. Emerging Infect Dis.. 2020;26(7):1478–1488.
   PubMed Web of Science ®Google Scholar
• Chandrashekar A, Liu J, Martinot AJ, et al. SARS-CoV-2 infection protects against rechallenge in rhesus macaques. Science. 2020;369(6505):812–817.
   PubMed Web of Science ®Google Scholar
• Woods A. Iceland scientists found 40 mutations of the coronavirus, report says 2020 [cited 2020 March 24]. Available from: https://nypost.com/2020/03/24/iceland-scientists-found-40-mutations-of-the-coronavirus-report-says/.
   Google Scholar
• Daniele Mercatelli FMG. Geographic and genomic distribution of SARS-CoV-2 mutations preprints 2020 [cited 2020 April 29]. Available from: https://www.preprints.org/manuscript/202004.0529/v1
   Google Scholar
• GISAID. Analysis update 2020 [June 12, 2020]. Available from: https://www.epicov.org/epi3/frontend#lightbox-649921485
   Google Scholar
• Jeong HW, Kim S-M, Kim H-S, et al. Viable SARS-CoV-2 in various specimens from COVID-19 patients. Clin Microbiol Infect. 2020;26(11):1520–1524.
   Web of Science ®Google Scholar
• Ibarrondo FJ, Fulcher JA, Goodman-Meza D, et al. Rapid decay of anti–SARS-CoV-2 antibodies in persons with mild Covid-19. N Engl J Med. 2020;383(11):1085–1087.
   PubMed Web of Science ®Google Scholar
• Patel MM, Thornburg NJ, Stubblefield WB, et al. Change in antibodies to SARS-CoV-2 over 60 days among health care personnel in Nashville, Tennessee. Jama. 2020;324(17):1781–1782.
   PubMed Web of Science ®Google Scholar
• Long Q-X, Tang X-J, Shi Q-L, et al. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat Med. 2020;26(8):1200–1204.
   PubMed Web of Science ®Google Scholar